MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

Search

Quanterix Corp

Închisă

SectorSănătate

3.3 -5.17

Rezumat

Modificarea prețului

24h

Curent

Minim

3.26

Maxim

3.45

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+114.29% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-127M

169M

Deschiderea anterioară

8.47

Închiderea anterioară

3.3

Sentimentul știrilor

By Acuity

50%

50%

168 / 349 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 apr. 2026, 00:00 UTC

Evenimente importante

ADB: Higher Energy Prices to Raise Production, Consumer Costs

10 apr. 2026, 00:00 UTC

Evenimente importante

ADB Projects Japan GDP Growth at 0.7% in 2026, 0.6% in 2027

10 apr. 2026, 00:00 UTC

Evenimente importante

ADB Projects South Korea GDP Growth at 1.9% in 2026, 1.9% in 2027

10 apr. 2026, 00:00 UTC

Evenimente importante

Extent of Slowdown Hinges on Duration of MidEast Conflict, ADB Says

10 apr. 2026, 00:00 UTC

Evenimente importante

ADB Projects India GDP Growth at 6.9% in 2026, 7.3% in 2027

10 apr. 2026, 00:00 UTC

Evenimente importante

ADB Projects China GDP Growth at 4.6% in 2026, 4.5% in 2027

10 apr. 2026, 00:00 UTC

Evenimente importante

ADB Pojects Australia GDP Grrowth at 2.0% in 2026, 2.9% in 2027

10 apr. 2026, 00:00 UTC

Evenimente importante

ADB Projects Taiwan GDP Growth at 7.6% in 2026, 4.0% in 2027

10 apr. 2026, 00:00 UTC

Evenimente importante

Geopolitical Risks Make Asia's Economic Outlook Highly Uncertain, ADB Says

10 apr. 2026, 00:00 UTC

Evenimente importante

Asia Regional Growth Likely to Moderate in 2026-2027, ADB Says

9 apr. 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

9 apr. 2026, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Inflation Concerns -- Market Talk

9 apr. 2026, 23:14 UTC

Market Talk

Jefferies Upbeat on Australian Miners, But Recession a Key Risk -- Market Talk

9 apr. 2026, 23:14 UTC

Market Talk

Global Equities Roundup: Market Talk

9 apr. 2026, 23:07 UTC

Market Talk

Centaurus's Supply Deal with Glencore Supports Jaguar Development -- Market Talk

9 apr. 2026, 22:54 UTC

Market Talk

Transurban Lacks Appeal as Higher Fuel Prices Slow Traffic -- Market Talk

9 apr. 2026, 22:31 UTC

Evenimente importante

Trump on Truth Social: 'That Is Not the Agreement We Have!'

9 apr. 2026, 22:31 UTC

Evenimente importante

Trump on Truth Social: 'Iran Is Doing a Very Poor Job, Dishonorable Some Would Say, of Allowing Oil to Go Through the Strait of Hormuz'

9 apr. 2026, 20:57 UTC

Evenimente importante

U.S. Oil Prices Are Back Near $100 After Israel Keeps Up Air Strikes on Lebanon -- Barrons.com

9 apr. 2026, 20:55 UTC

Câștiguri

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 apr. 2026, 20:55 UTC

Câștiguri

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 apr. 2026, 20:55 UTC

Câștiguri

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

9 apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

9 apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 apr. 2026, 20:40 UTC

Achiziții, Fuziuni, Preluări

Blackstone Investment Positions Rowan to Continue Delivering Sustainable Data Center Capacity for World's Leading Technology Cos >BX

9 apr. 2026, 20:39 UTC

Achiziții, Fuziuni, Preluări

Blackstone Blackstone Acquired Significant Minority Stake in Rowan Digital Infrastructure >BX

9 apr. 2026, 20:39 UTC

Achiziții, Fuziuni, Preluări

Rowan Digital Infrastructure Announces Strategic Recapitalization

9 apr. 2026, 20:25 UTC

Achiziții, Fuziuni, Preluări

SBA Communications Stock Soars on Buyout Interest. What It Means for Tower Stocks. -- Barrons.com

9 apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9 apr. 2026, 19:30 UTC

Evenimente importante

How Digital Currencies Have Helped Iran -- WSJ

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

114.29% sus

Prognoză pe 12 luni

Medie 7.5 USD  114.29%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

168 / 349 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat